Press Release
2025-04-14
CancerCare® Announces its 2025 National Gala Honoring ASCO, Bluprint Oncology and Petauri
CancerCare®, the leading national nonprofit organization providing free professional support services to anyone affected by cancer, is excited to announce its 2025 National Gala, which will be held on Tuesday, April 22, at the Ziegfeld Ballroom in New York City.
This year’s event will honor three exceptional entities and companies for their contributions and support of people diagnosed with cancer: the American Society of Clinical Oncology (ASCO), Bluprint Oncology—Powered by Petauri™ and Petauri. This year’s Dorothy Schachne Corporate Achievement Award will be awarded to Bluprint Oncology—Powered by Petauri and Petauri and the Dorothy Schachne Partners in Progress Award will be awarded to ASCO.
“We are pleased to honor these three organizations at this year’s gala,” said CancerCare CEO Christine Verini. “For over 80 years, CancerCare has addressed what matters most to patients and their families through our free services. This gala is a vital way to raise funds for our community and we are so grateful to everyone who participates each year. Thank you to ASCO, Bluprint Oncology and Petauri for their continued support of our mission.”
As the largest global professional society for oncologists, we are honored to work with CancerCare to help bridge the gap in needs and services for all patients and caregivers,” said Dr. Clifford Hudis, Chief Executive Officer, ASCO; Executive Vice Chair, Conquer Cancer, the ASCO Foundation. “Patients are the ultimate focus of all of ASCO’s work and therefore essential partners in our mission to deliver the highest quality of cancer care for every patient, everywhere. Patients’ perspectives and insights inform all of our programs and initiatives and we are especially grateful to CancerCare for the essential role it plays in our mutual efforts to improve the lives of people with cancer. We look forward to many more years of collaboration and impact.”
“This recognition underscores Bluprint Oncology's unwavering commitment to advancing care for individuals impacted by cancer. It is an honor to be recognized alongside such an esteemed organization as ASCO at this year’s CancerCare Gala. We remain dedicated to supporting the patients and families who inspire our work every day,” said Lisa Hefner, President, Bluprint Oncology.
Petauri is honored to support CancerCare and its unwavering dedication to providing essential resources, support, and guidance to those affected by cancer. At the core of our mission is advancing access to innovative treatments and improving patient outcomes. We are proud to contribute to an organization that ensures individuals and families facing cancer receive the care and support they deserve,” said Dan Renick, CEO of Petauri.
The 2025 CancerCare National Gala is made possible by the generous support of our sponsors. CancerCare would like to thank its 2025 Gala Co-Chairs Susan Smirnoff and Harvey Shapiro, Auction Co-Chairs, Joan Brower and Marsha Palanci, as well as the Gala Committee: Annette Alvarez Pizzo, Paul M. Friedman, Kay Hsu, Ellen Negrin, Michael Parisi, Eleanor Sigona and Burt & Susan Zweigenhaft.
Gala Sponsors include Premier Sponsor: The Schachne Family and Leadership Sponsors: Collection 18, Kay Hsu & Anthony Zaret and Merck. The Gala Gold Sponsors are: The Lauber-Palanci family, Lori & Michael Parisi and Susan Smirnoff & Kirk Zachary. Silver Sponsors include Amgen, the Association for Value-Based Cancer Care (AVBCC), Blaylock Van, LLC, Eisai, the Evans Family, Renata and Flavio Figueiredo, Susan and Paul Friedman, Gilead, Johnson & Johnson, McKesson, Carolyn & Walter Messner, Loretta and Raymond Moseman, Onco360, PINC AI Applied Sciences, Premier, Real Chemistry and Harvey Shapiro.
Learn more about CancerCare's National Gala.
About CancerCare®
For over 80 years, CancerCare has empowered millions of people affected by cancer through free counseling, support groups, educational resources, advocacy and financial assistance. Our oncology social workers improve the lives of people diagnosed with cancer, caregivers, survivors and the bereaved by addressing their emotional, practical and financial challenges. To learn more, visit www.cancercare.org.
About the American Society of Clinical Oncology
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to the principle that knowledge conquers cancer. Together with the Association for Clinical Oncology, ASCO represents more than 50,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of high quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. Conquer Cancer, the ASCO Foundation, supports ASCO by funding groundbreaking research and education across cancer’s full continuum. Learn more at www.ASCO.org, and follow us on Facebook, X, LinkedIn, Instagram, Bluesky, and YouTube.
About Bluprint Oncology—Powered by Petauri
Bluprint Oncology is a scientific communications agency that specializes in oncology and hematology medical and commercial strategy, engagement, and education. We are passionate about leveraging expert insights for relevant learnings and conveying science and data in compelling, credible communications tailored to your audience.
About Petauri
Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill Capital, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in global market access, medical affairs, commercialization support, patient services, and data and analytics. Since it was founded in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group, the agencies of FORCE Communications, Mtech Access, Delta Hat, the agencies of the Brightly Network, and Formulary Insights, all now Powered by Petauri™. The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances. From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care. For more information, please visit www.petauri.com.